Rayland Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.41 M
as on 23-12-2024
- Company Age 23 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.70 M
as on 23-12-2024
- Satisfied Charges ₹ 2.99 M
as on 23-12-2024
- Revenue -0.80%
(FY 2022)
- Profit -0.69%
(FY 2022)
- Ebitda 0.84%
(FY 2022)
- Net Worth 9.70%
(FY 2022)
- Total Assets -1.87%
(FY 2022)
About Rayland Diagnostic Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.41 M.
The company currently has active open charges totaling ₹9.70 M. The company has closed loans amounting to ₹2.99 M, as per Ministry of Corporate Affairs (MCA) records.
Sarmistha Saha and Bhaskar Saha serve as directors at the Company.
- CIN/LLPIN
U85195WB2001PTC093324
- Company No.
093324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2001
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location24-Pgs(N), West Bengal
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rayland Diagnostic Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarmistha Saha  | Director | 21-Jun-2001 | Current |
| Bhaskar Saha | Director | 21-Jun-2001 | Current |
Financial Performance of Rayland Diagnostic Centre.
Rayland Diagnostic Centre Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.8% decrease. The company also saw a slight decrease in profitability, with a 0.69% decrease in profit. The company's net worth moved up by a moderate rise of 9.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rayland Diagnostic Centre?
In 2019, Rayland Diagnostic Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 16 Nov 2015 | ₹9.70 M | Open |
West Bangal Financial Corporation Creation Date: 29 Jul 2004 | ₹2.99 M | Satisfied |
How Many Employees Work at Rayland Diagnostic Centre?
Rayland Diagnostic Centre has a workforce of 13 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rayland Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayland Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
